Condition
Controlled Human Malaria Infection
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Terminated1
Unknown1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06172686Phase 1UnknownPrimary
In-vivo Transmission Model in Semi-immune Adults
NCT03813108Not ApplicableTerminated
Safety and Efficacy of NF135 CPS Immunization
NCT03454048Not ApplicableCompleted
Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2
Showing all 3 trials